MEN-10755
MEN-10755 is a pharmaceutical drug currently under development by the biopharmaceutical company Menarini. It is being investigated for its potential use in the treatment of pulmonary arterial hypertension (PAH), a rare and severe condition characterized by high blood pressure in the arteries of the lungs.
Overview[edit | edit source]
MEN-10755 is a dual endothelin receptor antagonist (ERA), meaning it blocks the action of endothelin, a potent vasoconstrictor peptide. By blocking the action of endothelin, MEN-10755 is expected to dilate the blood vessels in the lungs, reducing the pressure and improving the symptoms of PAH.
Development[edit | edit source]
The development of MEN-10755 is currently in the clinical trial phase. The drug has shown promising results in preclinical studies, demonstrating a potent and long-lasting effect in reducing pulmonary arterial pressure. The ongoing clinical trials aim to confirm these results in patients with PAH.
Potential Impact[edit | edit source]
If successful, MEN-10755 could provide a new treatment option for patients with PAH, a condition for which there is currently no cure. The drug could potentially improve the quality of life and survival rates for these patients.
See Also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD